FDA extends Plavix patent by 6 months to May 2012

Jan 25, 2011 By MATTHEW PERRONE , AP Health Writer

(AP) -- The makers of Plavix, the world's second best-selling medication, said Tuesday they will retain exclusive U.S. marketing rights to the blood thinner for an additional six months, under a decision by U.S. health regulators.

The marketing extension will help Bristol-Myers Squibb Co. and partner Sanofi-Aventis delay the financial crunch hitting nearly all drugmakers, as patents on a wave of blockbuster drugs from the 1990s begin to expire.

The companies announced that the granted a six-month extension for Plavix after the companies conducted extra studies of the drug in infants. The FDA program is designed to reward companies for testing drugs in children, who are typically excluded from medical studies.

With the extension, the companies will be able to market the drug exclusively until May 17, 2012.

Plavix posted $9.1 billion in sales globally in 2009, according to health care data firm IMS Health. Only Pfizer's Lipitor had higher sales, at 13.3 billion. In the U.S., Plavix generated $5.6 billion.

New York-based Bristol-Myers faces one the starkest patent cliffs in the pharmaceutical industry, as four of its top five sellers lose patent protection between now and 2015. The company sells the schizophrenia drug Abilify and blood pressure medication Avapro, among other prescription medications.

French drugmaker Sanofi is already weathering its own revenue decline, after the FDA unexpectedly approved a generic version of its drug Lovenox, an injectable medication for preventing life-threatening blood clots.

Bristol-Myers studied in more than 900 infants born with a rare heart defect to see if the drug would reduce dangerous clotting. The study failed to show any benefit.

Drug companies routinely conduct such tests, even when success is not expected, to receive the six-month patent extension.

Explore further: Merck, Iowa firm sign Ebola vaccine licensing deal (Update)

not rated yet
add to favorites email to friend print save as pdf

Related Stories

FDA says heartburn drugs can interfere with Plavix

Nov 17, 2009

(AP) -- Federal health officials said Tuesday a popular variety of heartburn medications can interfere with the blood thinner Plavix, a drug taken by millions of Americans to reduce risks of heart attack ...

FDA warning: some patients cannot process Plavix

Mar 12, 2010

(AP) -- The Food and Drug Administration is adding its strongest warning to the label for Plavix, cautioning that some patients do not respond to the blockbuster blood thinner.

FDA clears Eli Lilly's blood thinner Effient

Jul 10, 2009

(AP) -- The Food and Drug Administration on Friday approved a highly anticipated blood thinner from Eli Lilly, though the drug must carry the agency's sternest warning because of its bleeding risks.

Bristol-Myers Squibb sees 3Q profit dip 2 percent

Oct 26, 2010

(AP) -- Bristol-Myers Squibb Co. posted a slight decline in third-quarter profit Tuesday as its restrained spending was offset by flat sales of its drugs, lower income from its partners and bigger discounts to government ...

Pfizer gets EU approval for kids' cholesterol drug

Jul 06, 2010

(AP) -- The European Union has approved a new chewable form of cholesterol blockbuster Lipitor for children 10 and up with high levels of bad cholesterol and triglycerides, a type of blood fat, Pfizer said Tuesday.

Recommended for you

Powdered measles vaccine found safe in early clinical trials

10 hours ago

A measles vaccine made of fine dry powder and delivered with a puff of air triggered no adverse side effects in early human testing and it is likely effective, according to a paper to be published November 28 in the journal ...

Health care M&A leads global deal surge

Nov 23, 2014

In a big year for deal making, the health care industry is a standout. Large drugmakers are buying and selling businesses to control costs and deploy surplus cash. A rising stock market, tax strategies and ...

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

CarolinaScotsman
not rated yet Jan 25, 2011
Of the seventeen medications I take, Plavix is the only non-generic. -Sigh- Guess I'll have to continue paying through the nose for a while longer.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.